FPF1100NW ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	3

6. Parkinson disease

---

Clinical trials : 2,298 /  Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-122000	01/4/2012	02/11/2012	Long-term study of FPF1100NW monotherapy	Long-term study on FPF1100NW monotherapy with early Parkinson's disease patients	Early Parkinson's disease	Intervention name : FPF1100NW INN of the intervention : Selegiline Dosage And administration of the intervention : oral Control intervention name : null	FP Pharmaceutical Corp.	NULL				BOTH	130	Phase 2	NULL
2	JPRN-JapicCTI-101020			Phase II study on FPF1100NW monotherapy	Study on FPF1100NW monotherapy with early Parkinson's disease patients (Phase II study)	Parkinson's disease	Intervention name : FPF1100NW INN of the intervention : Selegiline Dosage And administration of the intervention : oral Control intervention name : null	FP Pharmaceutical Corp.	NULL		20	74	BOTH	90	Phase 2	NULL
3	JPRN-JapicCTI-121954			Phase III study on FPF1100NW monotherapy	Randomized, double-blind, placebo-controlled study on FPF1100NW monotherapy with early Parkinson's disease patients (Phase III study)	Early Parkinson's disease	Intervention name : FPF1100NW INN of the intervention : Selegiline Dosage And administration of the intervention : oral Control intervention name : null	FP Pharmaceutical Corp.	NULL		20	74	BOTH	280	Phase 3	NULL